CD300a Antikörper (PE)
-
- Target Alle CD300a (CD300A) Antikörper anzeigen
- CD300a (CD300A)
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CD300a Antikörper ist konjugiert mit PE
-
Applikation
- Flow Cytometry (FACS)
- Spezifität
- The antibody MEM-260 reacts with an extracellular epitope of CD300a, a 60 kDa leukocyte transmembrane glycoprotein expressed on human granulocytes, monocytes, neutrophils, NK cells, mast cells and dendritic cells, 25 % of circulating T cells and 15 % of circulating B cells.
- Kreuzreaktivität (Details)
- Human
- Aufreinigung
- Purified antibody is conjugated with R-phycoerythrin (PE) under optimum conditions. Unconjugated antibody and free fluorochrome are removed by size-exclusion chromatography.
- Immunogen
- HPB human acute lymphoid leukemia cell line
- Klon
- MEM-260
- Isotyp
- IgG1
- Top Product
- Discover our top product CD300A Primärantikörper
-
-
- Applikationshinweise
- Flow cytometry: The reagent is designed for analysis of human blood cells using 20 μL reagent / 100 μL of whole blood or 106 cells in a suspension. The content of a vial (2 ml) is sufficient for 100 tests.
- Kommentare
-
The purified antibody is conjugated with R-Phycoerythrin (PE) under optimum conditions. The conjugate is purified by size-exclusion chromatography and adjusted for direct use. No reconstitution is necessary.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Rekonstitution
- No reconstitution is necessary.
- Buffer
- Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
-
Do not freeze.
Avoid prolonged exposure to light. - Lagerung
- 4 °C
- Informationen zur Lagerung
- Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.
-
- Target
- CD300a (CD300A)
- Andere Bezeichnung
- CD300a (CD300A Produkte)
- Synonyme
- CD300L-B1 antikoerper, CD300A antikoerper, clm8 antikoerper, B230315M08Rik antikoerper, Clm8 antikoerper, LMIR1 antikoerper, MAIR-I antikoerper, MAIR-Ia antikoerper, MMAC8 antikoerper, Pigr4 antikoerper, mcpir1 antikoerper, CLM-8 antikoerper, CMRF-35-H9 antikoerper, CMRF-35H antikoerper, CMRF35-H antikoerper, CMRF35-H9 antikoerper, CMRF35H antikoerper, CMRF35H9 antikoerper, IGSF12 antikoerper, IRC1 antikoerper, IRC1/IRC2 antikoerper, IRC2 antikoerper, IRp60 antikoerper, CD300 molecule like family member g antikoerper, CD300a molecule antikoerper, CMRF35-like molecule 8 antikoerper, CD300A molecule antikoerper, Cd300a molecule antikoerper, CD300LG antikoerper, CD300A antikoerper, LOC483289 antikoerper, clm8 antikoerper, Cd300a antikoerper
- Hintergrund
- CD300a molecule,CD300a (CMRF-35H, IRp60) is a non-MHC-specific inhibitory receptor of immunoglobulin superfamily, which contains three immunoreceptor tyrosine-based inhibitory motifs (ITIMs) that associate with SH2-containing phosphatases SHP-1 and SHP-2. CD300a is expressed on many cell types including T cells, NK cells, neutrophils, eosinophils or mast cells. Its triggering inhibits activating signals such as those of IL5, GM-CSF or eotaxin, as well as supresses mast cell degranulation or NK cell cytotoxic activity.,IRC, CLM-8, IGSF12, CMRF35H
- Gen-ID
- 11314
- UniProt
- Q9UGN4
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-